U.S. Prescribing Information including Boxed WARNING for ARISTADA INITIO^® and ARISTADA^® 

Medication Guides for ARISTADA INITIO^® and ARISTADA^®

Learn more at www.aristada.com 

U.S. Prescribing Information including Boxed WARNING for LUMRYZ^®

Medication Guide for LUMRYZ^®

Learn more at www.lumryz.com

U.S. Prescribing Information including Boxed WARNING for LYBALVI^®

Medication Guide for LYBALVI^®

Learn more at www.lybalvi.com

U.S. Prescribing Information for VIVITROL^®

Medication Guide for VIVITROL^®

Learn more at www.vivitrol.com

Medical Information

Healthcare professionals, patients and caregivers with questions can reach Alkermes Medical Information by phone at 1-888-235-8008 (Direct: 1-571-599-2702) Monday through Friday between 9 a.m. and 7 p.m. ET or by sending an email to medinfo@alkermes.com.

U.S. healthcare professionals are encouraged to visit the Alkermes Medical Information portal for assistance with medical inquiries. Please note that this portal is for U.S. healthcare professionals only.

Visit the Medical Information portal

LUMRYZ^® (sodium oxybate) Resources

For questions specific to LUMRYZ, following Alkermes' acquisition of Avadel Pharmaceuticals plc in February 2026, please use the following communication channels:

To obtain medical information on LUMRYZ, contact 1-888-8AVADEL (1-888-828-2335) or medinfo@avadel.com.

To report suspected adverse events or product complaints, contact 1-888-8AVADEL (1-888-828-2335) or productsafety@avadel.com.

LUMRYZ^® is a registered trademark of Flamel Ireland Limited, an affiliate of Alkermes plc.